Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001493152-25-018450·Cyclerion Therapeutics, Inc.
Schedule 13G ownership disclosure
CYCLERION THERAPEUTICS INC
Common Stock, no par value · CUSIP: 23255M204
Event date: 2025-03-25
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- J. Wood Capital Advisors LLC
Shares: 181,818.00 · Class: 5.4%
- Jason Wood
Shares: 181,818.00 · Class: 5.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-25-018450
- Form type
- SCHEDULE 13G
- Filer
- Cyclerion Therapeutics, Inc.
- CIK
- CIK 1755237
- Filed
- Oct 17, 2025
- Reporting period
- Mar 25, 2025
- Description
- Schedule 13G beneficial ownership